Indeed, as illustrated in Fig. 1A and B, PD1+CD28− T-cell clones show superior functionality compared to their PD1+CD28+ counterparts, both in terms of specific anti-tumor cytotoxicity (Fig. 1B, left) and concurrent production of lytic molecules (Fig. 1B, right). This evidence concerns the gene CD28 and neoplasm.